N

NN

NN

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish

Insider Buys

0

$0

Insider Sales

2

$196K

Total Volume

$196K

2 transactions

Net Activity

$196K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35Confidence

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Sector & Industry
Unknown Comparison
Industry Buy Conviction50%
NN Buy Conviction0%
Industry Rank#0 of 111
Volume Contribution0.0%
Total Industry Activity$0

NN has an insider buy conviction of 0%, compared to the Unknown sector buy average of 50%.

Top Insiders
Most active traders
G
1

Gray Timothy

CFO

0 buys1 sells

$163K total

I
2

Insley Susan Brasse

COO

0 buys1 sells

$34K total

Insider Trading Summary
Automated trend commentary

Over the last 90 days, corporate insiders at NN (NN) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 2 were sales. The total volume of insider trading reached $196K.

The net insider activity for NN shows a net selling bias of $196K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Gray Timothy (CFO), who traded 11.1K shares valued at $163K on Sep 23, 2026.

Trading History
NN insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 23, 2026

5 days ago

Gray Timothy

CFO

CFO
Sell11.1K$14.64$163K

Sep 24, 2026

4 days ago

Insley Susan Brasse

COO

COO
Sell2.4K$14.22$34K

Related News & Analyst Reports

Read original insights and educational research covering NN and the Unknown sector.

August 3, 2026

Lock-up Expiration Frontrunning: How Venture Funds Manage Large Block Trades

When lock-up periods expire, venture funds use block trades, 10b-18 programs, and coordinated secondary offerings to exit large positions. This report reveals the strategies that minimize price impact, and how retail investors can track them.

Read Analysis
August 2, 2026

Deciphering Form 5 Filings: Uncovering Annual Insider Gift Trades

A comprehensive guide to SEC Form 5 filings, explaining how annual reports of gift shares, stock options, and non-open-market transactions signal insider sentiment.

Read Analysis
May 14, 2026

Spotting Insider Sells: When to Worry and When to Ignore

Most insider sales are irrelevant, estate planning, tax obligations, diversification. But certain Form 4 selling patterns are genuine red flags. This guide teaches you exactly when to worry: cluster sells, CEO departures, and pre-restatement patterns.

Read Analysis
April 9, 2026

Insider Trading and Earnings Announcements: Spotting the Catalyst

How does insider trading activity in the 30 days before earnings compare to post-announcement prices? This study quantifies the predictive power of pre-earnings Form 4 purchases after accounting for blackout period compliance.

Read Analysis
March 20, 2026

Sequoia Capital and the Mechanics of Venture Lock-Up Extensions

Sequoia Capital pioneered the use of voluntary lock-up extensions to signal portfolio company confidence. This report analyzes the market-price impact of Sequoia extension announcements and whether they have historically justified the delay.

Read Analysis
September 15, 2025

Biotech Insider Buying: Analyzing Clinical Trial Catalysts

Biotech insiders walk a legal tightrope near trial readouts. This report identifies statistically significant buying clusters at small-cap biotechs 30-90 days before Phase 2 and Phase 3 data announcements.

Read Analysis

FAQs About NN Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for NN.

Based on SEC Form 4 disclosures, the Insider Confidence Score for NN is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 2 sales by company executives over the last 90 days.

The CEO Conviction Index for NN is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.